p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors

Bruton’s tyrosine kinase (BTK) is a non-receptor intracellular kinase playing a key role in the proliferation and survival of normal and malignant B-lymphocytes. Its targeting by Ibrutinib, the first specific inhibitor, represented a turning point for the therapy of certain types of B-cell leukemias...

Descripción completa

Detalles Bibliográficos
Autores principales: Grassilli, Emanuela, Cerrito, Maria Grazia, Bonomo, Sara, Giovannoni, Roberto, Conconi, Donatella, Lavitrano, Marialuisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215537/
https://www.ncbi.nlm.nih.gov/pubmed/34164404
http://dx.doi.org/10.3389/fcell.2021.690365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215537/
https://www.ncbi.nlm.nih.gov/pubmed/34164404
http://dx.doi.org/10.3389/fcell.2021.690365

Ejemplares similares